Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 4, Issue 3, Pages 131-139
http://dx.doi.org/10.1155/1997/717139
Quality of Life Symposium

A Systematic Overview of the Measurement Properties of the Chronic Respiratory Questionnaire

Yves Lacasse,1 Eric Wong,1 and Gordon Guyatt2

1Design, Measurement and Evaluation Program, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
2Department of Medicine and Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada

Copyright © 1997 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

BACKGROUND: Assessment of health-related quality of life (HRQL) of patients with chronic lung disease has become an important aspect of many clinical investigations. The authors examined the measurement properties of a disease-specific HRQL questionnaire, the Chronic Respiratory Questionnaire (CRQ), when used by independent investigators in clinical trials and observational studies.

METHODS: All published papers citing the original 1987 CRQ publication were identified using the Science Citation Index, and abstracts presented at international conferences were found by hand search. Clinical trials and observational studies were included if they reported data bearing on the CRQ’s measurement properties.

RESULTS: Of 90 papers and 20 abstracts, 32 met the inclusion criterion. CRQ domains of fatigue, mastery and emotional function have high reliability, and face, content and construct validity in differentiating among patients with better and worse HRQL. Because of its self-generated items, the dyspnea domain works less well in discriminating among patients with lesser and greater dyspnea. When CRQ has been used to evaluate treatment, all four domains have performed well in detecting small treatment effects. The minimal important difference in CRQ score (0.5 per item) provides guidance for both planning studies and interpreting results. To maximize CRQ interpretability, investigators should present results as the mean score per item within each domain on a seven-point scale.

CONCLUSION: The CRQ has proved valid and responsive to change. Its standardization and continued wide use will enhance the understanding of the impact of treatments on patients’ HRQL.